Sulfamethizole

磺胺甲二唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfamethizole
Drug Alias Name磺胺甲噻唑sulfametizolsulfamethizolum磺胺甲噻二唑磺胺甲基硫代二嗪 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial dihydropteroate synthase inhibitors
TargetsBacterial dihydropteroate synthase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1953/10/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth-Ayerst
Active IndicationsN/A
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeB05CA04D06BA04J01EB02 +[4] 
Related LinksWikipediaDrugBankKEGG